Bulletin
Investor Alert

Topics

Merck & Co.

/marketstate/country/us

After Hours

09/17/21

MRK
Merck & Co. Inc.
/zigman2/quotes/209956077/composite

$

71.37

Change

-0.31 -0.43%

Volume

Volume 3.15m

Quotes are delayed by 20 min

/zigman2/quotes/209956077/composite

Previous close

$ 71.97

$ 71.68

Change

-0.29 -0.40%

Day low

Day high

$70.89

$72.00

Open

52 week low

52 week high

$68.38

$82.28

Open

Video

Gearing Up for Big Tech Earnings

  • Gearing Up for Big Tech Earnings Gearing Up for Big Tech Earnings 9:48
    Betterment CEO'S Year-end Goals Betterment CEO'S Year-end Goals 3:31
    The 100th MarketBrief The 100th MarketBrief 10:46
    Biden Says Enough Vaccines for All U.S. Adults by End of May Biden Says Enough Vaccines for All U.S. Adults by End of May 1:32
1:28 p.m. Sept. 17, 2021 - By MarketWatch Automation
1:25 p.m. Sept. 17, 2021 - By MarketWatch Automation
1:14 p.m. Sept. 17, 2021 - By MarketWatch Automation
1:09 p.m. Sept. 17, 2021 - By MarketWatch Automation
1:05 p.m. Sept. 17, 2021 - By MarketWatch Automation
12:55 p.m. Sept. 17, 2021 - By MarketWatch Automation
1:29 p.m. Sept. 16, 2021 - By MarketWatch Automation
1:26 p.m. Sept. 16, 2021 - By MarketWatch Automation
1:16 p.m. Sept. 16, 2021 - By MarketWatch Automation
1:10 p.m. Sept. 16, 2021 - By MarketWatch Automation
1:06 p.m. Sept. 16, 2021 - By MarketWatch Automation
12:56 p.m. Sept. 16, 2021 - By MarketWatch Automation
12:41 p.m. Sept. 16, 2021 - By MarketWatch Automation
8:00 a.m. Sept. 16, 2021 - By MarketWatch Automation
1:28 p.m. Sept. 15, 2021 - By MarketWatch Automation
1:26 p.m. Sept. 15, 2021 - By MarketWatch Automation
1:15 p.m. Sept. 15, 2021 - By MarketWatch Automation
1:09 p.m. Sept. 15, 2021 - By MarketWatch Automation
1:05 p.m. Sept. 15, 2021 - By MarketWatch Automation
12:55 p.m. Sept. 15, 2021 - By MarketWatch Automation
12:41 p.m. Sept. 15, 2021 - By MarketWatch Automation
1:28 p.m. Sept. 14, 2021 - By MarketWatch Automation
1:25 p.m. Sept. 14, 2021 - By MarketWatch Automation
1:14 p.m. Sept. 14, 2021 - By MarketWatch Automation
1:09 p.m. Sept. 14, 2021 - By MarketWatch Automation
1:05 p.m. Sept. 14, 2021 - By MarketWatch Automation
12:55 p.m. Sept. 14, 2021 - By MarketWatch Automation
12:40 p.m. Sept. 14, 2021 - By MarketWatch Automation
4:38 a.m. Sept. 14, 2021 - By Jaimy Lee
Merck CEO: Authorization of its experimental antiviral COVID-19 treatment could come by year endMerck & Co. Inc. said it expects the company's experimental oral antiviral treatment for COVID-19 could get emergency authorization by the end of the year. "We expect to be able to see clinical data here in the back half of the year and still have the potential for an interim analysis and potential for emergency use authorization before year end," Merck CEO Robert Davis told investors at the Morgan Stanley Global Healthcare Conference on Monday. Merck and Ridgeback Biotherapeutics Inc. have been testing the investigational therapy, molnupiravir, in a Phase 3 clinical trial. There are few authorized or approved new COVID-19 treatments beyond the monoclonal antibodies developed by Eli Lilly & Co. , GlaxoSmithKline and Vir Biotechnology Inc. , and Regeneron Pharmaceuticals Inc. and Gilead Sciences Inc.'s Veklury. The medical community has called for easy-to-take medications that can treat the disease caused by SARS-CoV-2. The U.S. has already purchased 1.7 million courses of molnupiravir, dependent on authorization from regulators. Merck's stock is down 7.0% for the year, while the broader S&P 500 is up 18.9%.
1:28 p.m. Sept. 13, 2021 - By MarketWatch Automation
1:26 p.m. Sept. 13, 2021 - By MarketWatch Automation
1:15 p.m. Sept. 13, 2021 - By MarketWatch Automation
1:09 p.m. Sept. 13, 2021 - By MarketWatch Automation
1:06 p.m. Sept. 13, 2021 - By MarketWatch Automation
12:56 p.m. Sept. 13, 2021 - By MarketWatch Automation
12:41 p.m. Sept. 13, 2021 - By MarketWatch Automation
1:29 p.m. Sept. 10, 2021 - By MarketWatch Automation
1:26 p.m. Sept. 10, 2021 - By MarketWatch Automation
1:15 p.m. Sept. 10, 2021 - By MarketWatch Automation
1:09 p.m. Sept. 10, 2021 - By MarketWatch Automation
Browse topics:

Filter results by

Location

Us (104)

Asia Pacific (4)

Eu (2)

Europe (2)

China (1)

Link to MarketWatch's Slice.